Catalyst Pharmaceuticals
CPRX
$15.13
Share price
-1.37%
Change (1 day)
-12.69%
Change (1 year)
Categories
Operating Margin for Catalyst Pharmaceuticals (CPRX)
Operating Margin as of April 2024 (TTM): 48.88%
According to Catalyst Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 48.88%. At the end of 2021 the company had an Operating Margin of 37.20%.
Operating Margin history for Catalyst Pharmaceuticals from 2019 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | 37.20% | 7.23% |
| 2020 | 34.69% | 11.51% |
| 2019 | 31.11% | -100.44% |
| 2018 | -7,059.03% | |
| 2010 | -823.01% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -53.19% | 🇺🇸 USA |
 Pfizer PFE | 34.61% | -29.19% | 🇺🇸 USA |
 Abbott Laboratories ABT | 15.60% | -68.09% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | -88.19% | -280.42% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | -84.50% | -272.87% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 4.83% | -90.12% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.